MedTrace Logo

In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)

NCT00177190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2014-05-28

No results posted yet for this study

Summary

This is an in vitro evaluation of cutaneous T-cell lymphoma using patients' blood and tissue to evaluate immune responses related to identified tumor populations and dendritic/CD 8 cells.

Conditions

  • Cutaneous T-cell Lymphoma
  • Sezary Syndrome
  • Mycosis Fungoides

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Larisa J. Geskin, M.D. · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2005-01-31
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00177190 on ClinicalTrials.gov